Aridis Pharmaceuticals Inc (ARDS)
0.0625
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Aridis Pharmaceuticals Enterprise Value: 6.161M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 6.161M |
| May 30, 2024 | 6.049M |
| May 29, 2024 | 5.893M |
| May 28, 2024 | 6.009M |
| May 24, 2024 | 6.005M |
| May 23, 2024 | 5.760M |
| May 22, 2024 | 6.085M |
| May 21, 2024 | 5.916M |
| May 20, 2024 | 6.064M |
| May 17, 2024 | 5.934M |
| May 16, 2024 | 6.139M |
| May 15, 2024 | 5.831M |
| May 14, 2024 | 6.049M |
| May 13, 2024 | 6.161M |
| May 10, 2024 | 6.049M |
| May 09, 2024 | 6.005M |
| May 08, 2024 | 5.893M |
| May 07, 2024 | 6.317M |
| May 06, 2024 | 6.237M |
| May 03, 2024 | 6.116M |
| May 02, 2024 | 6.005M |
| May 01, 2024 | 5.994M |
| April 30, 2024 | 6.049M |
| April 29, 2024 | 5.898M |
| April 26, 2024 | 6.272M |
| Date | Value |
|---|---|
| April 25, 2024 | 6.272M |
| April 24, 2024 | 6.183M |
| April 23, 2024 | 6.205M |
| April 22, 2024 | 6.25M |
| April 19, 2024 | 6.049M |
| April 18, 2024 | 6.118M |
| April 17, 2024 | 6.317M |
| April 16, 2024 | 6.518M |
| April 15, 2024 | 6.495M |
| April 12, 2024 | 6.573M |
| April 11, 2024 | 6.650M |
| April 10, 2024 | 6.803M |
| April 09, 2024 | 6.370M |
| April 08, 2024 | 6.406M |
| April 05, 2024 | 6.785M |
| April 04, 2024 | 6.562M |
| April 03, 2024 | 6.566M |
| April 02, 2024 | 6.629M |
| April 01, 2024 | 6.562M |
| March 28, 2024 | 6.852M |
| March 27, 2024 | 6.707M |
| March 26, 2024 | 6.678M |
| March 25, 2024 | 6.847M |
| March 22, 2024 | 6.852M |
| March 21, 2024 | 6.674M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.760M
Minimum
May 23 2024
100.21M
Maximum
Sep 05 2019
34.00M
Average
30.29M
Median
Feb 13 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.083M |
| Total Expenses (Quarterly) | 0.869M |
| EPS Diluted (Quarterly) | -0.0022 |
| Earnings Yield | -259.5% |
| Normalized Earnings Yield | -1008.00 |